These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
439 related items for PubMed ID: 7945726
21. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex. Noji M, Kizu R, Takeda Y, Akiyama N, Yoshizaki I, Eriguchi M, Kidani Y. Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175 [Abstract] [Full Text] [Related]
22. Cytotoxicity and tolerance to DNA adducts of alicyclic mixed amine platinum(II) homologs in tumor models sensitive and resistant to cisplatin or tetraplatin. Yoshida M, Khokhar AR, Siddik ZH. Oncol Rep; 1998 Jun; 5(5):1281-7. PubMed ID: 9683851 [Abstract] [Full Text] [Related]
24. Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines. Kido Y, Khokhar AR, Siddik ZH. Anticancer Drugs; 1993 Apr; 4(2):251-8. PubMed ID: 8490203 [Abstract] [Full Text] [Related]
25. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide. Kushev D, Gorneva G, Taxirov S, Spassovska N, Grancharov K. Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821 [Abstract] [Full Text] [Related]
28. Drug resistance induction and cross-resistance studies with Pt-complexes. Hrubisko M, Balázová E, Ujházy V. Neoplasma; 1984 Nov; 31(6):649-53. PubMed ID: 6542968 [Abstract] [Full Text] [Related]
30. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV). Hagopian GS, Mills GB, Khokhar AR, Bast RC, Siddik ZH. Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719 [Abstract] [Full Text] [Related]
31. Murine anti-tumor activity of new water soluble platinum(II) complexes with reduced toxicity. Talebian AH, Bensely D, Schein PS, Green D. Anticancer Drug Des; 1990 Nov; 5(4):371-8. PubMed ID: 2291775 [Abstract] [Full Text] [Related]
32. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes. Hrubisko M, Balázová E, Kiss F, Kovácová J, Ujházy V. Neoplasma; 1989 Nov; 36(6):651-7. PubMed ID: 2615869 [Abstract] [Full Text] [Related]
38. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin. Twentyman PR, Wright KA, Mistry P, Kelland LR, Murrer BA. Cancer Res; 1992 Oct 15; 52(20):5674-80. PubMed ID: 1327513 [Abstract] [Full Text] [Related]
39. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation. Hoeschele JD, Showalter HD, Kraker AJ, Elliott WL, Roberts BJ, Kampf JW. J Med Chem; 1994 Aug 19; 37(17):2630-6. PubMed ID: 8064793 [Abstract] [Full Text] [Related]
40. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy. Sbovata SM, Bettio F, Mozzon M, Bertani R, Venzo A, Benetollo F, Michelin RA, Gandin V, Marzano C. J Med Chem; 2007 Sep 20; 50(19):4775-84. PubMed ID: 17713897 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]